Levodropropizine

左羟丙哌嗪

Report date: 2023/02/21 20:00:25
NME

Base Information

Drug NameLevodropropizine
Drug Alias Name左旋羟丙哌嗪levodropropizinumlevodropropizinaRapituxDanka +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsCough
Global Approved IndicationsCough
Approved Indications in ChinaCough
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Chengchuang Pharmaceutical Technology Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Neptunus Pharmaceutical Co Ltd
Inactive CompaniesShandong Chengchuang Pharmaceutical Technology Development Co Ltd
Active IndicationsCough
Inactive IndicationsN/A

Other Information

ATC CodeR05DB27
Related LinksWikipediaKEGG